| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
607 |
550 |
$1.10M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,851 |
2,457 |
$800K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
484 |
425 |
$519K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
579 |
564 |
$399K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,130 |
4,056 |
$293K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,510 |
3,496 |
$235K |
| 92250 |
|
5,184 |
5,153 |
$218K |
| 92083 |
|
3,437 |
3,416 |
$136K |
| 92134 |
|
3,748 |
3,658 |
$123K |
| 92133 |
|
3,140 |
3,111 |
$105K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,948 |
2,844 |
$104K |
| 65855 |
|
285 |
239 |
$72K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
1,125 |
1,119 |
$71K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
787 |
785 |
$68K |
| J9035 |
Injection, bevacizumab, 10 mg |
735 |
653 |
$60K |
| 68761 |
|
535 |
280 |
$36K |
| 92136 |
|
570 |
432 |
$35K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
685 |
663 |
$23K |
| 92020 |
|
517 |
512 |
$10K |
| 92273 |
|
43 |
43 |
$6K |
| 95930 |
|
206 |
206 |
$5K |
| 76514 |
|
383 |
375 |
$4K |
| 92235 |
|
13 |
13 |
$2K |
| 92275 |
|
46 |
46 |
$793.88 |
| 83861 |
|
12 |
12 |
$258.96 |
| 83516 |
|
12 |
12 |
$123.84 |